ChemBriefEmpowered Funds Takes New $4.95M Stake in Chemical Maker Stepan
Empowered Funds LLC increased its stake in specialty chemical maker Stepan by $4.95 million after the company surpassed Q2 revenue and EPS expectations.
Dealroom · 2026-09-01 08:57 UTC
Empowered Funds LLC increased its stake in specialty chemical maker Stepan by $4.95 million after the company surpassed Q2 revenue and EPS expectations.
Stepan Company reported mixed Q2 2026 financial results with stronger earnings but a six-month net loss while maintaining dividends, prompting investor analysis on converting specialty chemical assets
Various ETFs include Stepan Co stock in their portfolios, detailing fund metrics like AUM and expense ratios. This information assists investors in identifying diversified investment options primarily
Stepan Company shares have recovered over the past year despite a five-year decline, trading near their fair price-to-sales value of 0.6x. Future performance hinges on converting revenue to cash flow
Stepan Company reported approximately 2,301 employees worldwide as of March 2026, marking a 3.8% decline since 2023. Active job postings decreased by 60.9%, while the average global salary stands at $
Empowered Funds LLC increased its stake in Stepan Company by 124.8% to $8.7 million following strong quarterly earnings that beat estimates with 15% revenue growth.
Stepan Co CFO Ruben Dario Velasquez settled 1,358 RSUs at $64.675 per share on August 10, 2026, withholding 398 shares for taxes. The remaining 2,716 RSUs will vest ratably over three years without a
Wall Street Zen upgraded Stepan Company (NYSE:SCL) to a "Buy" rating following strong quarterly earnings that exceeded EPS and revenue expectations. The positive outlook drove shares up 1.8% to $65.14
Stepan Company reported strong Q2 2026 sales and net income while affirming its quarterly dividend. Analysts note significant undervaluation via DCF models despite mixed shareholder returns over three
Stepan Company exceeded Q2 revenue and EPS expectations, reporting $684 million and $1.00 respectively. Analysts forecast a 2026 loss but raised price targets, expecting Stepan to outpace industry rev
Stepan Company reported Q2 2026 sales of US$684.11 million and affirmed its quarterly dividend. Analysts highlight potential undervaluation against peers despite recent stock momentum.
The Public Employees Retirement System of Ohio reduced its stake in Stepan Company by 94.1% in Q1, while the firm reported strong earnings with 15% revenue growth.
Stepan Company reported strong Q2 results and affirmed its dividend, citing governance changes. While valuation models suggest the stock is undervalued, risks from net losses remain.
Stepan Company reaffirmed its dividend despite a net loss in the first half of 2026, aiming to clarify long-term strategy. Analysts project significant revenue growth by 2029, suggesting a potential 1
Stepan Co reported Q2 2026 revenue of $684.1 million with doubled net income, driven by higher prices and improved product mix in surfactants.
Stepan Company VP Matthew John Eaken filed a beneficial ownership statement disclosing 9,319 direct shares and 3,102 indirect shares via an ESOP II Trust. The filing also details his holdings in stock
Stepan Company reported a 102% surge in Q2 2026 net income driven by volume growth and margin recovery in Surfactants and Polymers. Simultaneously, the firm plans to reduce its global salaried workfor
Stepan Company declared a quarterly cash dividend of $0.395 per share, payable in September 2026, marking its 58th consecutive year of increases. As a major manufacturer of specialty chemicals and sur
Stepan Company declared a quarterly cash dividend of $0.395 per share, marking its 58th consecutive year of increases. The specialty chemical manufacturer produces surfactants and polyurethane polyols
Stepan CEO Luis Rojo stated Middle East tensions may drive continued customer pre-buying in Q3 after strong Q2 earnings. The company launched a $100 million efficiency initiative involving asset closu
Stepan Company is scheduled to release second-quarter earnings while executing its Project Catalyst restructuring plan. Analysts expect improved profitability driven by cost reductions and a shift tow
Stepan Co (SCL) holds a valuation score of 8.90, ranking 16th in the Chemicals industry, with a P/E ratio of -92.70 while other key metrics remain undisclosed.
Stepan Company reports a $1.30 billion market cap with the United States driving the majority of revenue alongside France. The article details the firm's financial performance across geographic region
Stepan Co (SCL) disclosed its major institutional shareholders, including BlackRock and Vanguard, highlighting investment advisors as the largest category. The report details historical shareholding d
Argus Research raised its target price for chemical manufacturer Stepan Company (SCL) to $62.00. The stock currently trades at $58.57 across its three business segments.
Argus Research raised its price target for Stepan Company (SCL) to $60.00, noting the firm manufactures diverse chemicals and chemical-based products. The stock currently trades at $57.57 following th
Stepan Company reported mixed 2024 financial results with declining net sales but improved profitability driven by lower raw material costs and a richer product mix in its specialty chemicals segment.
Stepan Company will release its second quarter 2026 earnings results on July 29, 2026, accompanied by a conference call and webcast replay.
Stepan Company will release its second-quarter 2026 earnings results on July 29, 2026, followed by a conference call with executives to discuss financial and operational performance.
Stepan Company discusses its outlook amid evolving specialty chemicals demand, manufacturing surfactants and polymers for industries including cleaning, personal care, agriculture, and energy.
TradingView provides financial data access for Stepan Company, displaying enterprise value to revenue forward metrics along with market tools and community features.
TradingView displays financial metrics for Stepan Co (FWB:96S), focusing on enterprise value to revenue forward while noting the market was closed with no trades.
Stepan Company (NYSE: SCL) forward price-to-earnings ratio data is displayed on TradingView, with the market noted as closed during the viewing period.
Stepan Company offers access to financial disclosures and regulatory filings from Q1 FY22 to Q1 FY2026. Reports cover earnings, investor presentations, and strategic initiatives like Project Catalyst.
TradingView displays the Enterprise Value to EBIT forward metric for Stepan Company (NYSE:SCL), reflecting current market performance data.
Stepan Company joined the Russell 2000 Dynamic Index, with analysts suggesting a 27% undervaluation at $75 per share. Growth drivers include profit recovery and the new Pasadena, Texas site expected t
Analysts project Stepan Company (SCL) shares to hit a $75.00 price target by 2027 based on financial performance, advising investors to conduct further research before trading.
This article provides an overview of Stepan Company's stock performance, including current pricing, historical trends, analyst forecasts, and key financial metrics such as earnings and dividends.
Stepan Company highlights STEPANOL WA-1003, a high-activity anionic liquid surfactant used as a base for household and industrial cleaners. The product features strong foaming and wetting properties w
Stepan Co (SCL) tops the Chemicals industry with a 10.00 institutional shareholding score, seeing a 12.78% quarterly increase in ownership to 97.83%. Bill Nygren (OAKMX) holds the largest stake with 1
Stepan Company, a global manufacturer of specialty chemicals, trades at $52.72 with a 'Sell' analyst consensus despite projected earnings growth of 66.81%.
Stepan Company, a specialty chemicals maker, releases an analyst consensus snapshot detailing earnings prospects, valuation, and dividend policies. The report covers market views on revenue, EPS, marg
Analysts project Stepan Co (SCL) revenue of $635.85 million and EPS of $0.65 for the upcoming quarter, maintaining a positive outlook within the Chemicals industry. The average price target stands at
Stepan Company shares have declined from recent highs, prompting investors to re-evaluate valuation amid cyclical pressures. As a specialty chemicals producer, its fundamentals and dividend policy are
US LABSA prices jumped 4.78% due to feedstock hikes and Sasol's force majeure, creating a supply crisis. Stepan Company raised prices, locking out small buyers amidst geopolitical tensions.
Stepan Co. shares declined 16% following fourth-quarter earnings that missed analyst expectations, continuing a trend of mixed results from earlier quarters in 2025.
Stepan Company VP Richard Finn received new equity compensation including stock appreciation rights and restricted stock units. An amended Form 4 corrected an administrative error regarding the conver
Stepan Company director Jan Stern Reed was granted 2,566 shares at $52.61 per share on May 8, 2026. He now holds 16,477 shares following the equity award with no insider sales.
Stepan Company VP Robin Joseph Weitkamp reported vesting of 90 RSUs on May 11, 2026, with 50 shares withheld for taxes at $52.58 each.
The global alpha olefin sulfonate market is projected to reach $942.6 million by 2030, growing at a CAGR of 5.47% driven by cleaning applications. Major players include Stepan, Clariant, Nouryon, Kao,